Hepatic protein kinase Cβ antagonizing p38 MAPK to activate ERK1/2 to dysregulate biliary lipid composition upon lithogenic stress
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025
DOI: 10.1152/ajpgi.00208.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Yaoling Shu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States. Hauptthemen laut MEDLINE: Protein Kinase C beta, MAP Kinase Signaling System, Cholelithiasis, Liver. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Ohio State University (OSU).
Abstract (Originalsprache)
This study underscores the pivotal role of hepatic PKCβ in controlling biliary lipid composition under lithogenic stress. Our findings on the distinct and combined effects of downstream p38 MAPK and ERK1/2 offer key insights into the mechanisms driving lithogenic diet-induced dysregulation of biliary lipid composition. This research reveals that the potential of PKCβ/p38 MAPK /ERK1/2 signaling axis offers the possibility for the integration of different inputs to modulate the signaling output balancing in a way most appropriate for context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
- Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.
- Department of Biochemistry and Molecular Biology, Holling Cancer Center, Medical University of South Carolina, Charleston, South Carolina, United States.
- Division of Metabolic Syndrome, Instacare Therapeutics, Dublin, Ohio, United States.
ORCID-Profile: Wei Huang, Kamal D Mehta
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- Ohio State University (OSU)
Zitieren
APA
Shu, Y., Rai, A., Sizemore, G. M., Ostrowski, M., Huang, W., & Mehta, K. D. (2025). Hepatic protein kinase Cβ antagonizing p38 MAPK to activate ERK1/2 to dysregulate biliary lipid composition upon lithogenic stress. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00208.2025
Vancouver
Shu Y, Rai A, Sizemore GM, Ostrowski M, Huang W, Mehta KD. Hepatic protein kinase Cβ antagonizing p38 MAPK to activate ERK1/2 to dysregulate biliary lipid composition upon lithogenic stress. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00208.2025
BibTeX
@article{Shu2025,
author = {Shu, Yaoling and Rai, Amit and Sizemore, Gina M and Ostrowski, Michael and Huang, Wei and Mehta, Kamal D},
title = {Hepatic protein kinase Cβ antagonizing p38 MAPK to activate ERK1/2 to dysregulate biliary lipid composition upon lithogenic stress},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2025},
doi = {10.1152/ajpgi.00208.2025}
}
EUVIMED